blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1939288

EP1939288 - T-CELL ADHESION MOLECULE AND ANTIBODY DIRECTED AGAINST THE MOLECULE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  25.10.2013
Database last updated on 11.09.2024
Most recent event   Tooltip17.07.2015Lapse of the patent in a contracting state
New state(s): HU		published on 19.08.2015  [2015/34]
Applicant(s)For all designated states
Eisai R&D Management Co., Ltd.
6-10, Koishikawa 4-chome, Bunkyo-ku
Tokyo 112-8088 / JP
[2008/27]
Inventor(s)01 / OGASAWARA, Hideaki, @KAN Research Institute Inc.
Kobe MI R&D Center, 7-3, Minatojima-Minamimachi
6-Chome, Chuo-Ku, Kobe-Shi, Hyogo-Ken 650-0047 / JP
02 / MIZUNO, Keiko, @KAN Research Institute Inc.
Kobe MI R&D Center, 7-3, Minatojima-Minamimachi
6-Chome, Chuo-Ku, Kobe-Shi, Hyogo-Ken 650-0047 / JP
03 / ARITA, Yoshihisa, @KAN Research Institute Inc.
Kobe MI R&D Center, 7-3, Minatojima-Minamimachi
6-Chome, Chuo-Ku, Kobe-Shi, Hyogo-Ken 650-0047 / JP
04 / NISHIMURA, Miyuki, @KAN Research Institute Inc.
Kobe MI R&D Center, 7-3, Minatojima-Minamimachi
6-Chome, Chuo-Ku, Kobe-Shi, Hyogo-Ken 650-0047 / JP
05 / IMAI, Toshio, @KAN Research Institute Inc.
Kobe MI R&D Center, 7-3, Minatojima-Minamimachi
6-Chome, Chuo-Ku, Kobe-Shi, Hyogo-Ken 650-0047 / JP
 [2012/51]
Former [2008/33]01 / OGASAWARA, Hideaki, KAN Research Institute Inc.
Kobe MI R&D Center, 7-3, Minatojima-Minamimachi
6-Chome, Chuo-Ku, Kobe-Shi, Hyogo-Ken 650-0047 / JP
02 / MIZUNO, Keiko, KAN Research Institute Inc.
Kobe MI R&D Center, 7-3, Minatojima-Minamimachi
6-Chome, Chuo-Ku, Kobe-Shi, Hyogo-Ken 650-0047 / JP
03 / ARITA, Yoshihisa, KAN Research Institute Inc.
Kobe MI R&D Center, 7-3, Minatojima-Minamimachi
6-Chome, Chuo-Ku, Kobe-Shi, Hyogo-Ken 650-0047 / JP
04 / NISHIMURA, Miyuki, KAN Research Institute Inc.
Kobe MI R&D Center, 7-3, Minatojima-Minamimachi
6-Chome, Chuo-Ku, Kobe-Shi, Hyogo-Ken 650-0047 / JP
05 / IMAI, Toshio, KAN Research Institute Inc.
Kobe MI R&D Center, 7-3, Minatojima-Minamimachi
6-Chome, Chuo-Ku, Kobe-Shi, Hyogo-Ken 650-0047 / JP
Former [2008/27]01 / OGASAWARA, Hideaki, KAN Research Institute Inc.
Science Center Building 3 93 Chudoji-Awata-cho Shimogyo-ku
Kyoto-shi Kyoto 6008815 / JP
02 / MIZUNO, Keiko, KAN Research Institute Inc.
Science Center Building 3 93 Chudoji-Awata-cho Shimogyo-ku
Kyoto-shi Kyoto 6008815 / JP
03 / ARITA, Yoshihisa, KAN Research Institute Inc.
Science Center Building 3 93 Chudoji-Awata-cho Shimogyo-ku
Kyoto-shi Kyoto 6008815 / JP
04 / NISHIMURA, Miyuki, KAN Research Institute Inc.
Science Center Building 3 93 Chudoji-Awata-cho Shimogyo-ku
Kyoto-shi Kyoto 6008815 / JP
05 / IMAI, Toshio, KAN Research Institute Inc.
Science Center Building 3 93 Chudoji-Awata-cho Shimogyo-ku
Kyoto-shi Kyoto 6008815 / JP
Representative(s)Brearley, Helen Rebecca
Elkington and Fife LLP
Prospect House
8 Pembroke Road
Sevenoaks
Kent TN13 1XR / GB
[N/P]
Former [2012/51]Brearley, Helen Rebecca
Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks
Kent TN13 1XR / GB
Former [2008/27]Brearley, Helen Rebecca
Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks
Kent TN13 1XR / GB
Application number, filing date06810939.629.09.2006
[2008/27]
WO2006JP319576
Priority number, dateJP2005028519429.09.2005         Original published format: JP 2005285194
[2008/27]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2007037430
Date:05.04.2007
Language:JA
[2007/14]
Type: A1 Application with search report 
No.:EP1939288
Date:02.07.2008
Language:EN
[2008/27]
Type: B1 Patent specification 
No.:EP1939288
Date:19.12.2012
Language:EN
[2012/51]
Search report(s)International search report - published on:JP05.04.2007
(Supplementary) European search report - dispatched on:EP26.04.2010
ClassificationIPC:C07K14/705, C07K16/28
[2012/30]
CPC:
C07K14/7051 (EP,US); C07K14/47 (KR); A61P19/02 (EP);
A61P29/00 (EP); A61P37/00 (EP); A61P37/06 (EP);
A61P43/00 (EP); C07K16/00 (KR); C07K16/28 (EP,US);
C07K16/2803 (EP,US); C07K2317/76 (EP,US); C07K2319/30 (EP,US);
G01N2333/7051 (EP,US); G01N2500/02 (EP,US) (-)
Former IPC [2008/27]C12N15/09, C07K14/47, C07K16/18, C12N5/10, C12Q1/02, C12Q1/68, A61K39/395, A61P29/00, A61P37/06, A61P43/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/27]
Extension statesAL31.03.2008
BA31.03.2008
HR31.03.2008
MK31.03.2008
RS31.03.2008
TitleGerman:T-ZELLADHÄSIONSMOLEKÜL UND GEGEN DAS MOLEKÜL GERICHTETER ANTIKÖRPER[2008/27]
English:T-CELL ADHESION MOLECULE AND ANTIBODY DIRECTED AGAINST THE MOLECULE[2008/27]
French:MOLÉCULE D'ADHÉSION DE LYMPHOCYTE T ET ANTICORPS DIRIGÉ CONTRE LA MOLÉCULE[2008/27]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase31.03.2008Translation filed 
31.03.2008National basic fee paid 
31.03.2008Search fee paid 
31.03.2008Designation fee(s) paid 
31.03.2008Examination fee paid 
Examination procedure31.03.2008Examination requested  [2008/27]
24.11.2010Amendment by applicant (claims and/or description)
09.05.2011Despatch of a communication from the examining division (Time limit: M06)
17.11.2011Reply to a communication from the examining division
17.07.2012Communication of intention to grant the patent
31.10.2012Fee for grant paid
31.10.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  09.05.2011
Opposition(s)20.09.2013No opposition filed within time limit [2013/48]
Fees paidRenewal fee
31.03.2008Renewal fee patent year 03
11.09.2009Renewal fee patent year 04
14.09.2010Renewal fee patent year 05
22.09.2011Renewal fee patent year 06
20.09.2012Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU29.09.2006
AT19.12.2012
BE19.12.2012
CY19.12.2012
CZ19.12.2012
EE19.12.2012
FI19.12.2012
LT19.12.2012
LV19.12.2012
MC19.12.2012
PL19.12.2012
RO19.12.2012
SI19.12.2012
SK19.12.2012
TR19.12.2012
BG19.03.2013
GR20.03.2013
IS19.04.2013
PT19.04.2013
[2015/34]
Former [2015/32]AT19.12.2012
BE19.12.2012
CY19.12.2012
CZ19.12.2012
EE19.12.2012
FI19.12.2012
LT19.12.2012
LV19.12.2012
MC19.12.2012
PL19.12.2012
RO19.12.2012
SI19.12.2012
SK19.12.2012
TR19.12.2012
BG19.03.2013
GR20.03.2013
IS19.04.2013
PT19.04.2013
Former [2014/20]AT19.12.2012
BE19.12.2012
CY19.12.2012
CZ19.12.2012
EE19.12.2012
FI19.12.2012
LT19.12.2012
LV19.12.2012
MC19.12.2012
PL19.12.2012
RO19.12.2012
SI19.12.2012
SK19.12.2012
BG19.03.2013
GR20.03.2013
IS19.04.2013
PT19.04.2013
Former [2013/40]AT19.12.2012
BE19.12.2012
CY19.12.2012
CZ19.12.2012
EE19.12.2012
FI19.12.2012
LT19.12.2012
LV19.12.2012
PL19.12.2012
RO19.12.2012
SI19.12.2012
SK19.12.2012
BG19.03.2013
GR20.03.2013
IS19.04.2013
PT19.04.2013
Former [2013/37]AT19.12.2012
BE19.12.2012
CY19.12.2012
CZ19.12.2012
EE19.12.2012
FI19.12.2012
LT19.12.2012
LV19.12.2012
PL19.12.2012
RO19.12.2012
SI19.12.2012
SK19.12.2012
BG19.03.2013
GR20.03.2013
IS19.04.2013
Former [2013/36]AT19.12.2012
BE19.12.2012
CY19.12.2012
CZ19.12.2012
EE19.12.2012
FI19.12.2012
LT19.12.2012
LV19.12.2012
PL19.12.2012
SI19.12.2012
SK19.12.2012
BG19.03.2013
GR20.03.2013
IS19.04.2013
Former [2013/35]BE19.12.2012
CY19.12.2012
CZ19.12.2012
EE19.12.2012
FI19.12.2012
LT19.12.2012
LV19.12.2012
SI19.12.2012
SK19.12.2012
BG19.03.2013
GR20.03.2013
IS19.04.2013
Former [2013/34]BE19.12.2012
FI19.12.2012
LT19.12.2012
LV19.12.2012
SI19.12.2012
BG19.03.2013
GR20.03.2013
IS19.04.2013
Former [2013/33]BE19.12.2012
FI19.12.2012
LT19.12.2012
LV19.12.2012
SI19.12.2012
GR20.03.2013
Former [2013/26]FI19.12.2012
LT19.12.2012
LV19.12.2012
SI19.12.2012
GR20.03.2013
Former [2013/24]FI19.12.2012
LT19.12.2012
LV19.12.2012
GR20.03.2013
Former [2013/23]FI19.12.2012
LT19.12.2012
LV19.12.2012
Former [2013/22]FI19.12.2012
LT19.12.2012
Former [2013/20]LT19.12.2012
Documents cited:Search[XA]WO0155335  (HYSEQ INC [US], et al) [X] 2,5-9,18-24 * page 20, line 19 - page 21, line 12 * * page 51, line 6 - line 9 * * page 68, line 19 - page 69, line 29 * * page 77, line 8 - line 28 * * page 94, line 7 - page 106, line 3 * * SEQ ID NO: 66 * [A] 12,13,25-31;
 [XI]  - "Mus musculus B6-derived CD11 +ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F730223I20 product:hypothetical Immunoglobulin-like/Immunoglobulin subtype/Ig-like domain profile containing protein, full insert sequence.", EMBL, (20050906), Database accession no. AK155804, URL: EBI, XP003011533 [X] 1,3,4 * the whole document * [I] 7,8,10,11
 [XI]  - "Novel human secreted and transmembrane protein PRO7425.", Geneseq, (20040129), Database accession no. ADD85423, URL: EBI, XP002575948 [X] 14-16 * the whole document * [I] 17
 [X]  - "LEUKOCYTE IMMUNOGLOBULIN RECEPTOR-LIKE (LIR-LIKE) PROTEIN No. 8", Geneseq, (20020225), Database accession no. AAU10510, URL: EBI, XP002575947 [X] 2,5,6 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.